A randomized trial of factor VIII and neutralizing antibodies in hemophilia A F Peyvandi, PM Mannucci, I Garagiola, A El-Beshlawy, M Elalfy, ... New England Journal of Medicine 374 (21), 2054-2064, 2016 | 522 | 2016 |
Thalassemia in Iran: epidemiology, prevention, and management H Abolghasemi, A Amid, S Zeinali, MH Radfar, P Eshghi, MS Rahiminejad, ... Journal of Pediatric Hematology/Oncology 29 (4), 233-238, 2007 | 348 | 2007 |
Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study H Abolghasemi, P Eshghi, AM Cheraghali, AAI Fooladi, FB Moghaddam, ... Transfusion and Apheresis Science 59 (5), 102875, 2020 | 215 | 2020 |
Factor XIII deficiency in Iran: a comprehensive review of the literature A Dorgalaleh, M Naderi, MS Hosseini, S Alizadeh, S Hosseini, S Tabibian, ... Seminars in thrombosis and hemostasis 41 (03), 323-329, 2015 | 90 | 2015 |
Clinical, immunologic, molecular analyses and outcomes of iranian patients with LRBA deficiency: a longitudinal study G Azizi, H Abolhassani, SA Mahdaviani, Z Chavoshzadeh, P Eshghi, ... Pediatric Allergy and Immunology 28 (5), 478-484, 2017 | 86 | 2017 |
Dental health and oral health‐related quality of life in children with congenital bleeding disorders K Salem, P Eshghi Haemophilia 19 (1), 65-70, 2013 | 76 | 2013 |
A randomized clinical trial evaluating the immunomodulatory effect of convalescent plasma on COVID-19-related cytokine storm M Pouladzadeh, M Safdarian, P Eshghi, H Abolghasemi, AG Bavani, ... Internal and emergency medicine, 1-11, 2021 | 70 | 2021 |
Coronavirus disease 2019 (COVID‐19) and decrease in blood donation: experience of Iranian Blood Transfusion Organization (IBTO) S Mohammadi, SMT Yazdi, P Eshghi, AH Norooznezhad Vox sanguinis 115 (7), 595, 2020 | 66 | 2020 |
Palliative care for children with cancer in the Middle East: A comparative study LK Mojen, M Rassouli, P Eshghi, AA Sari, MH Karimooi Indian journal of palliative care 23 (4), 379, 2017 | 66 | 2017 |
Hepatitis B and C virus infections in patients with hemophilia in Zahedan, southeast Iran. B Sharifi-Mood, P Eshghi, E Sanei-Moghaddam, M Hashemi Saudi medical journal 28 (10), 1516-1519, 2007 | 65 | 2007 |
Efficacy of autologous fibrin glue for primary pterygium surgery with conjunctival autograft A Foroutan, F Beigzadeh, MJ Ghaempanah, P Eshghi, N Amirizadeh, ... JOURNAL OF CURRENT OPHTHALMOLOGY 23 (1), 39-47, 2011 | 60 | 2011 |
Molecular basis and prenatal diagnosis of β‐thalassemia among Balouch population in Iran E Miri‐Moghaddam, A Zadeh‐Vakili, Z Rouhani, M Naderi, P Eshghi, ... Prenatal diagnosis 31 (8), 788-791, 2011 | 52 | 2011 |
Potential of therapeutic plasmapheresis in treatment of COVID-19 patients: Immunopathogenesis and coagulopathy S Balagholi, R Dabbaghi, P Eshghi, SA Mousavi, F Heshmati, ... Transfusion and Apheresis Science 59 (6), 102993, 2020 | 51 | 2020 |
Timing and severity of inhibitor development in recombinant versus plasma‐derived factor VIII concentrates: a SIPPET analysis F Peyvandi, A Cannavò, I Garagiola, R Palla, PM Mannucci, ... Journal of Thrombosis and Haemostasis 16 (1), 39-43, 2018 | 50 | 2018 |
Current understanding in diagnosis and management of factor XIII deficiency M Naderi, A Dorgalaleh, S Tabibian, S Alizadeh, P Eshghi, G Solaimani Iranian journal of pediatric hematology and oncology 3 (4), 164, 2013 | 46 | 2013 |
Efficacy of prophylaxis and genotype‐phenotype correlation in patients with severe Factor X deficiency in Iran M Karimi, A Vafafar, S Haghpanah, M Payandeh, P Eshghi, H Hoofar, ... Haemophilia 18 (2), 211-215, 2012 | 44 | 2012 |
Growth impairment in β-thalassemia major: the role of trace element deficiency and other potential factors P Eshghi, S Alavi, S Ghavami, A Rashidi Journal of pediatric hematology/oncology 29 (1), 5-8, 2007 | 44 | 2007 |
Identification of potential predictive markers of dexamethasone resistance in childhood acute lymphoblastic leukemia N Dehghan-Nayeri, M Rezaei-Tavirani, MD Omrani, A Gharehbaghian, ... Journal of cell communication and signaling 11, 137-145, 2017 | 39 | 2017 |
Molecular analysis of sixteen unrelated factor XIIIA deficient families from south‐east of Iran CH Trinh, W Sh ElSayed, P Eshghi, E Miri‐Moghaddam, A Zadeh‐Vakili, ... British journal of haematology 140 (5), 581-584, 2008 | 37 | 2008 |
Source of factor VIII replacement (plasmatic or recombinant) and incidence of inhibitory alloantibodies in previously untreated patients with severe hemophilia A: the … F Peyvandi, PM Mannucci, I Garagiola, M Elalfy, A El-Beshlawy, ... Blood 126 (23), 5, 2015 | 36 | 2015 |